Lv31
270 积分 2026-01-19 加入
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
2小时前
待确认
TNFR2-targeting biologics: Molecular mode of action, possible applications, and future developments
2小时前
已完结
TNFR2 Signaling in Musculoskeletal Diseases: Implications for Rheumatoid Arthritis and Osteoarthritis
2小时前
求助中
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
5天前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
6天前
已完结
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials
9天前
已完结
Commonalities Between pDCs and B Cells
11天前
已关闭
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
20天前
已完结
Positive results for obinutuzumab in SLE phase III trial
21天前
已完结
Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions
23天前
已完结
皖公网安备34019202002308
